Pluri Inc. (PLUR)
NASDAQ: PLUR · IEX Real-Time Price · USD
5.37
-0.08 (-1.47%)
At close: May 1, 2024, 3:38 PM
5.10
-0.27 (-5.03%)
After-hours: May 1, 2024, 6:07 PM EDT
Pluri Revenue
Pluri had revenue of $357.00K in the twelve months ending December 31, 2023, with 10.53% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $105.00K with 5,150.00% year-over-year growth. In the fiscal year ending June 30, 2023, Pluri had annual revenue of $287.00K with 22.65% growth.
Revenue (ttm)
$357.00K
Revenue Growth
+10.53%
P/S Ratio
77.99
Revenue / Employee
$2,902
Employees
123
Market Cap
27.84M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 287.00K | 53.00K | 22.65% |
Jun 30, 2022 | 234.00K | - | - |
Jun 30, 2021 | 0 | - | - |
Jun 30, 2020 | 23.00K | -31.00K | -57.41% |
Jun 30, 2019 | 54.00K | 4.00K | 8.00% |
Jun 30, 2018 | 50.00K | - | - |
Jun 30, 2017 | 0 | - | - |
Jun 30, 2016 | 2.85M | 2.47M | 651.19% |
Jun 30, 2015 | 379.00K | - | - |
Jun 30, 2014 | 379.00K | -300.00K | -44.18% |
Jun 30, 2013 | 679.00K | -37.00K | -5.17% |
Jun 30, 2012 | 716.00K | - | - |
Jun 30, 2011 | 0 | - | - |
Jun 30, 2010 | 0 | - | - |
Jun 30, 2009 | 0 | - | - |
Jun 30, 2008 | 0 | - | - |
Jun 30, 2007 | 0 | - | - |
Jun 30, 2006 | 0 | - | - |
Jun 30, 2005 | 0 | - | - |
Jun 30, 2004 | 0 | - | - |
Jun 30, 2003 | 0 | - | - |
Jun 30, 2002 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nutex Health | 247.65M |
Qilian International Holding Group | 46.47M |
NeuroOne Medical Technologies | 2.82M |
bioAffinity Technologies | 2.53M |
Nutriband | 2.09M |
Femasys | 1.07M |
PLUR News
- 23 days ago - Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method - GlobeNewsWire
- 4 weeks ago - Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences - GlobeNewsWire
- 5 weeks ago - Pluri Inc. Announces 1-for-8 Reverse Share Split - GlobeNewsWire
- 5 weeks ago - Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report - GlobeNewsWire
- 6 weeks ago - Engage with Pluri's Talent: Exciting Conference Appearances Ahead - GlobeNewsWire
- 6 weeks ago - Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing - GlobeNewsWire
- 7 weeks ago - Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation - GlobeNewsWire
- 2 months ago - Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board - GlobeNewsWire